Live News EQUITY FLASH L impact Nov 02, 2026, 02:25 PM UTC UroGen Pharma Says First Patient Dosed in UGN-501 Phase 1 Trial Valid market news retained in the public archive without immediate LiveCast distribution. URGN SquawkNews Desk